267 related articles for article (PubMed ID: 25633468)
21. Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis.
Frattini F; Crestani S; Vescovi PP; Franchini M
Hematology; 2013 May; 18(3):181-2. PubMed ID: 23321335
[TBL] [Abstract][Full Text] [Related]
22. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
Nakajima H; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
[TBL] [Abstract][Full Text] [Related]
23. Hyposensitization trial using salazosulfapyridine in a case of mesalamine intolerance.
Soga K; Itani K
Clin J Gastroenterol; 2019 Dec; 12(6):578-582. PubMed ID: 31037567
[TBL] [Abstract][Full Text] [Related]
24. [THREE CASES OF DRUG-INDUCED PNEUMONIA CAUSED BY MESALAZINE].
Akiyama N; Yokomura K; Nozue T; Abe T; Matsui T; Suda T
Arerugi; 2015 Dec; 64(10):1334-40. PubMed ID: 26727138
[TBL] [Abstract][Full Text] [Related]
25. Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.
Ferrusquía J; Pérez-Martínez I; Gómez de la Torre R; Fernández-Almira ML; de Francisco R; Rodrigo L; Riestra S
World J Gastroenterol; 2015 Apr; 21(13):4069-77. PubMed ID: 25852295
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
Chojnacki C; Wisniewska-Jarosinska M; Walecka-Kapica E; Klupinska G; Jaworek J; Chojnacki J
J Physiol Pharmacol; 2011 Jun; 62(3):327-34. PubMed ID: 21893693
[TBL] [Abstract][Full Text] [Related]
27. Mesalamine desensitization in a patient with treatment refractory ulcerative colitis and aspirin and nonsteroidal anti-inflammatory drug hypersensitivity.
Heath JL; Heath RD; Tamboli C; Johnson L; Wilson AS; Chervinskiy S; Bell MC; Kennedy JL
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):518-520. PubMed ID: 28284977
[No Abstract] [Full Text] [Related]
28. Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis.
Gibson PR; Fixa B; Pekárková B; Bátovský M; Radford-Smith G; Tibitanzl J; Gabalec L; Florin TH; Greinwald R
Aliment Pharmacol Ther; 2006 Apr; 23(7):1017-26. PubMed ID: 16573804
[TBL] [Abstract][Full Text] [Related]
29. Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.
Fleming K; Ashcroft A; Alexakis C; Tzias D; Groves C; Poullis A
World J Gastroenterol; 2015 Mar; 21(11):3376-9. PubMed ID: 25805947
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.
Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M
J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045
[TBL] [Abstract][Full Text] [Related]
31. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
Tsuboi R; Matsumoto S; Miyatani H; Mashima H
Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
[TBL] [Abstract][Full Text] [Related]
32. [Case of ulcerative colitis induced by mesalazine with acute aggravated colitis-like symptoms].
Inatsuchi S; Nakajima T; Yoshio Y; Entani A; Okada K
Nihon Shokakibyo Gakkai Zasshi; 2004 Sep; 101(9):989-92. PubMed ID: 15478662
[No Abstract] [Full Text] [Related]
33. MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
Sandborn WJ; Kamm MA; Lichtenstein GR; Lyne A; Butler T; Joseph RE
Aliment Pharmacol Ther; 2007 Jul; 26(2):205-15. PubMed ID: 17593066
[TBL] [Abstract][Full Text] [Related]
34. [A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis].
Kim KH; Kim TN; Jang BI
Korean J Gastroenterol; 2007 Dec; 50(6):379-83. PubMed ID: 18159175
[TBL] [Abstract][Full Text] [Related]
35. The effect of third-party reporting on adoption of evidence-based mesalazine regimens in ulcerative colitis: an observational study.
Kruis W; Leifeld L; Morgenstern J; Pfützer R; Reimers B; Ceplis-Kastner S;
J Crohns Colitis; 2013 May; 7(4):e125-32. PubMed ID: 22951030
[TBL] [Abstract][Full Text] [Related]
36. Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis.
Connolly MP; Poole CD; Currie CJ; Marteau P; Nielsen SK
Digestion; 2009; 80(4):241-6. PubMed ID: 19828955
[TBL] [Abstract][Full Text] [Related]
37. Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.
Langhorst J; Varnhagen I; Schneider SB; Albrecht U; Rueffer A; Stange R; Michalsen A; Dobos GJ
Aliment Pharmacol Ther; 2013 Sep; 38(5):490-500. PubMed ID: 23826890
[TBL] [Abstract][Full Text] [Related]
38. The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients.
Solomon D; Yarlas A; Hodgkins P; Karlstadt R; Yen L; Kane S
Aliment Pharmacol Ther; 2012 Jun; 35(12):1386-96. PubMed ID: 22536781
[TBL] [Abstract][Full Text] [Related]
39. The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis.
Irvine EJ; Yeh CH; Ramsey D; Stirling AL; Higgins PD
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1278-86. PubMed ID: 18808446
[TBL] [Abstract][Full Text] [Related]
40. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
Tolia V
Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
